Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903).
Gynecol Oncol. 2021 Dec;163(3):524-530. doi: 10.1016/j.ygyno.2021.09.010. Epub 2021 Oct 5.
Gynecol Oncol. 2021.
PMID: 34625284
Clinical Trial.
Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903).
Friedlander M, Benson C, O'Connell RL, Reed N, Clamp A, Lord R, Millan D, Nottley S, Amant F, Steer C, Anand A, Mileshkin L, Beale P, Banerjee S, Bradshaw N, Kelly C, Carty K, Divers L, Alexander L, Edmondson R.
Friedlander M, et al. Among authors: nottley s.
Gynecol Oncol. 2021 Apr;161(1):160-165. doi: 10.1016/j.ygyno.2021.02.016. Epub 2021 Feb 16.
Gynecol Oncol. 2021.
PMID: 33608144
Clinical Trial.
Item in Clipboard
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Mileshkin L, Edmondson R, O'Connell RL, Sjoquist KM, Andrews J, Jyothirmayi R, Beale P, Bonaventura T, Goh J, Hall M, Clamp A, Green J, Lord R, Amant F, Alexander L, Carty K, Paul J, Scurry J, Millan D, Nottley S, Friedlander M; PARAGON study group.
Mileshkin L, et al. Among authors: nottley s.
Gynecol Oncol. 2019 Jul;154(1):29-37. doi: 10.1016/j.ygyno.2019.05.007. Epub 2019 May 23.
Gynecol Oncol. 2019.
PMID: 31130288
Free article.
Clinical Trial.
Item in Clipboard
A phase 2 study of anastrozole in patients with oestrogen receptor and/progesterone receptor positive recurrent/metastatic granulosa cell tumours/sex-cord stromal tumours of the ovary: The PARAGON/ANZGOG 0903 trial.
Banerjee SN, Tang M, O'Connell RL, Sjoquist K, Clamp AR, Millan D, Nottley S, Lord R, Mullassery VM, Hall M, Gourley C, Bonaventura T, Goh JC, Sykes P, Grant PT, McNally O, Alexander L, Kelly C, Carty K, Divers L, Bradshaw N, Edmondson RJ, Friedlander M; PARAGON investigators.
Banerjee SN, et al. Among authors: nottley s.
Gynecol Oncol. 2021 Oct;163(1):72-78. doi: 10.1016/j.ygyno.2021.07.024. Epub 2021 Aug 16.
Gynecol Oncol. 2021.
PMID: 34412908
Clinical Trial.
Item in Clipboard
Unravelling undifferentiated soft tissue sarcomas: insights from genomics.
Hames-Fathi S, Nottley SWG, Pillay N.
Hames-Fathi S, et al. Among authors: nottley swg.
Histopathology. 2022 Jan;80(1):109-121. doi: 10.1111/his.14446.
Histopathology. 2022.
PMID: 34958500
Review.
Item in Clipboard
Subclassification of epithelioid sarcoma with potential therapeutic impact.
Haefliger S, Chervova O, Davies C, Nottley S, Hargreaves S, Sumathi VP, Amary F, Tirabosco R, Pillay N, Beck S, Flanagan AM, Lyskjaer I.
Haefliger S, et al. Among authors: nottley s.
J Pathol. 2023 Aug;260(4):368-375. doi: 10.1002/path.6135. Epub 2023 Jun 14.
J Pathol. 2023.
PMID: 37316954
Free PMC article.
Item in Clipboard
No-biopsy strategy for coeliac disease is applicable in adult patients: a 'real-world' Scottish experience.
Hoyle A, Gillett P, Gillett HR, Borg R, Nottley S, Farrow S, Elgoweini M, Elhassan M, Fletcher J, Whannel G, Gracie E, Morgan S, Jafferbhoy H, Dunbar L, Reid G, Metcalfe EL, Smith G, Harris S, Robertson C, Thomas M, Younger H, Furrie E.
Hoyle A, et al. Among authors: nottley s.
Frontline Gastroenterol. 2022 Aug 11;14(2):97-102. doi: 10.1136/flgastro-2022-102254. eCollection 2023.
Frontline Gastroenterol. 2022.
PMID: 36818788
Free PMC article.
Item in Clipboard
Cite
Cite